Recent Articles

  • All
  • Research

A Report of Adverse Effects Associated With the Administration of Cannabidiol in Healthy Dogs

Abstract Cannabis-based therapies have been used for centuries for various medicinal purposes. They have recently gained recognition as an effective treatment for medical conditions in humans; and, as such, awareness is increasing among veterinarians and pet owners. However, side effects, pharmacokinetics, and efficacy in dogs are not known. The purpose of this study was to…
Read More

Results From CBD Clinical Trial to Assess Efficacy on Seizure Frequency in Dogs ‘Encouraging’

Promising, and exciting. Those are the words used by Dr. Stephanie McGrath to describe new findings from a trailblazing pilot study to assess the use of cannabidiol, or CBD, for dogs with epilepsy. McGrath, a neurologist at Colorado State University’s James L. Voss Veterinary Teaching Hospital, led a small study with 16 pet dogs to assess…
Read More

Clinical Trials Commence for CBD Pet Products

Products using hemp-derived cannabidiol (CBD) designed for pets is not a new concept; Companies have been marketing CBD pet products for quite some time now, making their way into pet stores across the United States. Some pet owners have embraced the trend, using CBD oil to calm pets down, help alleviate joint pain as well…
Read More

Pharmacokinetics, Safety, and Clinical Efficacy of Cannabidiol Treatment in Osteoarthritic Dogs

Objectives: The objectives of this study were to determine basic oral pharmacokinetics, and assess safety and analgesic efficacy of a cannabidiol (CBD) based oil in dogs with osteoarthritis (OA). Methods: Single-dose pharmacokinetics was performed using two different doses of CBD enriched (2 and 8 mg/kg) oil. Thereafter, a randomized placebo-controlled, veterinarian, and owner blinded, cross-over study was…
Read More

On October 6, 2021, California Governor Gavin Newsom signed AB 45 into law, which allows for the inclusion of hemp and cannabinoids (e.g., CBD), extracts, or derivatives of hemp in food and beverages, dietary supplements, cosmetics, and processed pet food provided that they, among other things, contain less than 0.3% THC.

Read More →

An act to add and repeal Section 26013.2 of the Business and Professions Code, to amend Sections 11018.5, 100425, and 110065 of, to add Sections 110036, 110407, 110469, 110611, 111691, and 113091 to, to add Chapter 9 (commencing with Section 111920) to Part 5 of Division 104 of, and to repeal Section 111921.6 of, the Health and Safety Code, relating to industrial hemp, and declaring the urgency thereof, to take effect immediately.

Read More →